Our Strength is in Our Strategy
Safeguard focuses on partnering with growth-stage, entrepreneurial companies that have a competitive advantage in a high-growth market.
We have identified five key strategic themes that span across both the Technology and Life Sciences industries.
Maturity
Existing technologies and therapies are reaching the end of their designed lives or patent protection. The U.S. population is aging. Industry segments are consolidating.
Migration
Businesses are adopting new technologies and revenue-generation models as cost structures change. Medical treatments are moving toward earlier intervention.
Convergence
Technology and life sciences are intersecting in fields like medical devices, targeted diagnostics and therapies.
Compliance
Regulatory compliance – including requirements from HIPAA, Sarbanes-Oxley, The Patriot Act, and the FDA – drives business spending in both technology and life sciences.
Cost Containment
Businesses are always looking to contain spiraling costs in IT infrastructure and healthcare.
Strategic themes such as these tend to attract visionary and innovative entrepreneurs who need capital support and strategic guidance. These promising growth-stage entrepreneurial companies already have a competitive advantage and are the ideal partners for Safeguard.
Our Market Focus
We focus on acquiring primary or minority stakes in technology and life sciences companies with attractive growth prospects and capital requirements of $5 million to $50 million. We prefer candidates in large or growing markets located in the United States and Canada with competitive barriers to entry, such as proprietary technology and intellectual property.